Overview

This trial is active, not recruiting.

Condition asthma
Treatments primary care clinical pathway, asthma education
Sponsor University of Alberta
Collaborator Alberta Innovates Health Solutions
Start date June 2015
End date June 2017
Trial size 22 participants
Trial identifier NCT02481037, 201400389

Summary

At least half of children with asthma have poor disease control, which can result in complications requiring emergency treatment and hospitalization. As asthma is one of the most common reasons for children to visit emergency departments (ED) and be hospitalized, this disease places a heavy burden on the health care system and families. While there is strong evidence that timely treatment with preventative therapies can substantially improve asthma control, reduce sudden worsening of symptoms, and lower rates of ED visits and hospitalizations, a significant proportion of children do not receive these therapies.

The purpose of this study is to improve the prescription and use of evidenced-based preventative therapies for children with asthma with the goal to significantly improve their disease control and quality of life, while reducing unnecessary ED visits and hospitalizations. The investigators will achieve this by: i) installing a primary care clinical pathway for managing childhood asthma into clinicians' electronic medical record (EMR) to facilitate the use of best-evidence by practitioners, and ii) training chronic disease management (CDM) health professionals to provide targeted and timely asthma education to parents and children with asthma. The investigators will test this pathway and education project in a representative sample of 22 Alberta primary care practices, using a pragmatic cluster controlled trial methodology.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose health services research
Arm
(Experimental)
Embedding a primary care clinical pathway for managing childhood asthma into clinicians' electronic medical record (EMR) to facilitate practitioners utilizing best-evidence, and training these practices' chronic disease management (CDM) professionals to provide asthma education to children with asthma and their parents.
primary care clinical pathway
Installing a primary care clinical pathway for managing childhood asthma into clinicians' electronic medical record (EMR) to facilitate the use of best-evidence by practitioners.
asthma education
Physicians will receive web-based education through an interactive learning module regarding best management for childhood asthma and use of the primary care clinical pathway. Chronic disease management (CDM) health professionals in practices will attend asthma education sessions delivered by an asthma educator. This training will be then used by the CDM professional to provide targeted and timely asthma education to parents and children with asthma.
(No Intervention)
Practice will continue with routine care. Control group will be offered the intervention at study completion, if successful.

Primary Outcomes

Measure
Dispensed preventative therapies
time frame: 12 months after receiving intervention

Secondary Outcomes

Measure
Prescription of evidenced-based preventative therapies
time frame: 12 months after receiving intervention
Emergency department visits and hospitalizations for asthma
time frame: 12 months after receiving intervention
Electronic Medical Record (EMR) data
time frame: 12 months after receiving intervention
Economic Analysis Costs
time frame: 12 months after receiving intervention

Eligibility Criteria

Male or female participants from 1 year up to 17 years old.

Inclusion Criteria: - Validated diagnosis of asthma according to CPCSSN validated definition Exclusion Criteria: - Children under 1 and over 17 years of age - Children of parents who have opted out of CPCSSN data collection - Children with validated asthma who have not attended practices in the last 2 years, or have not received bronchodilator therapy in the last 12 months

Additional Information

Official title Primary Care Pathway for Childhood Asthma
Principal investigator Andrew Cave, FCFP, FRCGP
Trial information was received from ClinicalTrials.gov and was last updated in September 2016.
Information provided to ClinicalTrials.gov by University of Alberta.